Medical network on April 17 - recently, diving technology intended to transfer 1.6 billion yuan price Wan Dong medical 22% stake in the health shu melting the actual control of people come to the attention of capital markets and the Shanghai stock exchange. 

 

It is worth mentioning, diving from the hand of the China resources of science and technology will Wan Dong medical only took over two years. According to the transaction prices, diving technology shares held Wan Dong medical value has 2 times, value of more than 2 billion yuan. Wan Dong medical treatment, however, in 2016 in the consolidated net profit attributable to shareholders of listed companies is RMB 71.54 million, higher than in 2014 2014 yuan only. 

 

Equity market value increment 

 

That time, diving technology acquisition Wan Dong medical (formerly known as CRC Wan Dong) equity is considered to be "snake". 

 

On March 3, 2014, huarun Wan Dong announcement, according to the actual control company plans to pull out of the medical equipment business strategic China China resources corporation, for this purpose, the company holding shares of northeast pharmaceutical group plans to transfer 111.501 million shares held by the company (accounts for 51.51% of the total equity of the company), at the same time, China proposed by the Shanghai united assets and equity exchange public stock transfer held by Shanghai medical instruments (group) co., LTD. 100% stake. 

 

In September 2014, China resources Wan Dong said, diving technology to a deal price 1.14 billion yuan to buy CRC Wan Dong above 111.501 million shares. Since then, China resources Wan Dong suspended suspension notice for the major issues of the planning. In June 2015, huarun Wan Dong issued the purchase plan, the non-public a-share issuance of objects including kuang-ming wu, which DE novo, ChengYu investment, rosefinch, Tibet ruihua, Song Wenlei and CRC Wan Dong medical equipment co., LTD. 2015 annual employee stock ownership plan, raise funds total does not exceed 880 million yuan, the number of non-public a-share total 24.957459 million shares. 

 

Huarun Wan Dong announcement, on July 2, 2015, diving technology by Shanghai stock exchange trading system to $40.982 per share prices to increase company 395457 shares, accounting for the number of shares in a company has issued 216 million shares of 0.18%. According to this calculation, the value added cost about 16.21 million yuan. 

 

In April 2016, China resources more than 2015 annual profit allocation and capital reserves east turn add equity plan, according to the company in the total equity base about 241 million shares, to all the shareholders with capital reserve for every 10 shares turn add 6 shares; In September 2016, China resources Wan Dong renamed Wan Dong medical treatment. After the above changes in equity, 2016 annual report, diving medical technology hold Wan Dong about 180 million shares, stake of 46.68%. 

 

Nowadays, diving through the way of introducing strategic investors of science and technology to achieve the cash out. Released on April 11, 2017, Wan Dong medical reports on equity changes of Jane said, diving technology by way of contract transfer to yu melt transfer its holdings of Wan Dong medical infinite prise 84.9854 million shares, accounting for 22% of the total equity Wan Dong medical. Changes in the rights and interests, after diving technology shares held Wan Dong medical accounted for 24.68% of its total equity. The share transfer price of 19.5 yuan/shares, share transfer to the price paid in cash, the total price of 1.657 billion yuan. 

 

For the changes in equity, the world science and technology, said the one is based on their needs and financial arrangements, 2 it is deliberately through the equity transfer agreement, for the introduction of powerful investors of listed companies, in order to adjust the ownership structure of listed companies and promote sustained profitability. 

 

It is worth mentioning that the transaction price is calculated, diving Wan Dong medical 46.68% held by the technology of market value of about 3.51 billion yuan. This means that when diving technology investment of 1.14 billion yuan, now value exceeds 2 billion yuan. At present, the Wan Dong medical treatment in a suspended state, the last trading day's closing price of 18.12 yuan/share. 

 

Profits increase exceeds 45 million yuan for two years 

 

However, compared to diving into the science and technology since the equity market capitalisation, more than 2 billion yuan of value-added Wan Dong medical performance change is "trivial". 

 

An unnamed industry insiders "securities journal" reporter interview, said the China resources exit Wan Dong medical, because the medical devices sector performance is not ideal. After diving into main Wan Dong medical treatment, however, the results did not achieve qualitative change. "Integration requires time". 

 

Wan Dong medical annual report in 2014, during the reporting period, the company operating income of 739.87 million yuan, down 3.24% year-on-year, to realize belong to shareholders of listed companies net profit of 25.6925 million yuan, fell 41.1% year on year; In 2016, Wan Dong medical operating income of 813 million yuan, total profit is 81.01 million yuan, up 62.36%; Attributable to shareholders of listed companies net profit of 71.54 million yuan, up 77.54% from 2015. 

 

On the basis of calculation, diving into the science and technology for two years, Wan Dong health net profit growth of 45.8475 million yuan, only for its equity market capitalisation value-added 2.29% (calculated according to 2 billion yuan). 

 

In addition, the world science and technology, the other a diving medical 2016 annual report of listed companies, the company operating income of 2.633 billion yuan, up 25.14% year on year, operating profit of 541 million yuan, up 44.02% from a year earlier, attributable to shareholders of listed companies deducting non-recurring gains and losses net profit of 489 million yuan, up 39.53% from a year earlier.